Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LONALeonaBio, Inc.

Nasdaq · CIK 0001620463
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts227

Identity from submissions API

NameLeonaBio, Inc.
CIK0001620463
TickersLONA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN453368487
LEI—
Fiscal year end1231
State of incorporation—
Phone(425) 620-8501
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Athira Pharma, Inc. (2019-09-19T04:00:00.000Z → 2026-01-08T05:00:00.000Z)
  • M3 Biotechnology, Inc. (2014-10-03T04:00:00.000Z → 2019-01-23T05:00:00.000Z)
Business address
18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL
WA
98011
WA
Mailing address
18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL
WA
98011
WA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

472 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q 10-Q 0001193125-26-463518 001-39503 261560874 34 12299291 1 1
2026-11-16 8-K 8-K 2.02,7.01,9.01 0001193125-26-463483 001-39503 261560686 34 323048 1 1
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-004525 005-91705 261552152 34 19098
2026-11-04 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-004856 005-91705 261521913 34 12903
2026-10-28 4 PRIMARY DOCUMENT 0002126186-26-000002 8350
2026-10-28 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001655566-26-000004 005-91705 261495537 34 14705
2026-10-26 4 4 0001193125-26-431896 20285
2026-10-26 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-431897 005-91705 261485866 34 10406
2026-09-22 8-K 8-K 8.01 0001193125-26-397952 001-39503 261397086 34 154713 1 1
2026-09-03 3 PRIMARY DOCUMENT 0002126186-26-000001 4704
2026-08-31 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001655566-26-000003 005-91705 261347008 34 1092055
2026-08-26 8-K 8-K 8.01 0001193125-26-368288 001-39503 261322685 34 159187 1 1
2026-08-25 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-365096 005-91705 261315610 34 12575
2026-08-20 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001636587-26-000069 005-91705 261297822 34 12642
2026-08-14 10-Q 10-Q 0001193125-26-352243 001-39503 261281615 34 11586409 1 1
2026-08-14 8-K 8-K 2.02,7.01,9.01 0001193125-26-352208 001-39503 261281408 34 338047 1 1
2026-07-10 4 4 0001193125-26-300876 10339
2026-07-09 4 4 0001193125-26-299927 10362
2026-06-24 4 xslF345X06/form4-06242026_100631.xml 0001843393-26-000006 5982
2026-06-24 4 xslF345X06/form4-06242026_100652.xml 0001580111-26-000010 6038
2026-06-24 4 xslF345X06/form4-06242026_100642.xml 0001790314-26-000004 6000
2026-06-24 4 xslF345X06/form4-06242026_100601.xml 0001679039-26-000003 5924
2026-06-24 4 xslF345X06/form4-06242026_100643.xml 0001722055-26-000005 5868
2026-06-24 4 xslF345X06/form4-06242026_100602.xml 0001164426-26-000003 5907
2026-06-24 4 xslF345X06/form4-06242026_100614.xml 0001225501-26-000003 5916
2026-06-24 4 xslF345X06/form4-06242026_100627.xml 0001763316-26-000004 5883
2026-06-24 4 xslF345X06/form4-06242026_100648.xml 0001258693-26-000011 5905
2026-06-23 8-K 8-K 5.07 0001193125-26-279425 001-39503 261111037 34 197412 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062870 005-91705 26990408 34 16122
2026-05-11 ARS ARS 0001193125-26-217029 001-39503 26964201 34 5742295
2026-05-11 DEFA14A DEFA14A 0001193125-26-217016 001-39503 26964135 34 1308715
2026-05-11 DEF 14A DEF 14A 0001193125-26-216742 001-39503 26964036 34 4503439 1 1
2026-05-07 4 xslF345X06/form4-05082026_120559.xml 0001580111-26-000007 5898
2026-05-07 4 xslF345X06/form4-05082026_120552.xml 0001790314-26-000003 5860
2026-05-07 4 xslF345X06/form4-05082026_120544.xml 0001843393-26-000004 5842
2026-05-07 3 xslF345X06/form3-05082026_120509.xml 0001790314-26-000002 12532
2026-05-07 3 xslF345X06/form3-05082026_120521.xml 0001580111-26-000006 12565
2026-05-07 3 xslF345X06/form3-05082026_120524.xml 0001843393-26-000003 12518
2026-05-07 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-212047 005-91705 26953743 34 12143
2026-05-07 10-Q 10-Q 0001193125-26-211898 001-39503 26953306 34 10602315 1 1
2026-05-07 8-K 8-K 2.02,7.01,9.01 0001193125-26-211867 001-39503 26953118 34 351609 1 1
2026-04-13 4 xslF345X06/form4-04132026_080418.xml 0001679039-26-000002 5897
2026-04-13 4 xslF345X06/form4-04132026_080410.xml 0001822499-26-000006 5868
2026-04-13 4 xslF345X06/form4-04132026_080453.xml 0001763316-26-000002 5856
2026-04-13 4 xslF345X06/form4-04132026_080428.xml 0001258693-26-000008 5878
2026-04-13 4 xslF345X06/form4-04132026_080426.xml 0001722055-26-000004 5841
2026-04-13 4 xslF345X06/form4-04132026_080417.xml 0001225501-26-000002 5889
2026-04-13 4 xslF345X06/form4-04132026_080406.xml 0001164426-26-000002 5880
2026-04-13 4 xslF345X06/form4-04132026_080459.xml 0001794629-26-000006 5881
2026-04-13 4 xslF345X06/form4-04132026_080445.xml 0001191906-26-000002 5854
2026-04-13 4 xslF345X06/form4-04132026_080440.xml 0001861464-26-000006 5878
2026-04-13 4 xslF345X06/form4-04132026_080430.xml 0002037968-26-000006 5916
2026-04-13 4 xslF345X06/form4-04132026_080417.xml 0001604834-26-000008 5913
2026-04-02 424B3 424B3 0001193125-26-138620 333-292826 26830371 33 465559
2026-04-02 424B3 424B3 0001193125-26-138619 333-292829 26830370 33 290820
2026-04-01 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001046 333-292829 26830452 33 1906
2026-04-01 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001045 333-292826 26830451 33 1906
2026-04-01 S-8 S-8 0001193125-26-137879 333-294822 26828175 33 451848 1 1
2026-04-01 S-8 S-8 0001193125-26-137873 333-294820 26828124 33 490844 1 1
2026-03-31 CORRESP filename1.htm 0001193125-26-134946 11596
2026-03-31 CORRESP filename1.htm 0001193125-26-134930 11596
2026-03-31 S-1/A S-1/A 0001193125-26-134904 333-292829 26823250 33 1076583 1 1
2026-03-31 S-1/A S-1/A 0001193125-26-134866 333-292826 26823115 33 1276106 1 1
2026-03-31 10-K 10-K 0001193125-26-134565 001-39503 26821864 34 19207775 1 1
2026-03-31 8-K/A 8-K/A 2.01,9.01 0001193125-26-134097 001-39503 26820625 34 1374313 1 1
2026-03-26 8-K 8-K 2.02,7.01,9.01 0001193125-26-126579 001-39503 26799284 34 21180543 1 1
2026-03-19 8-K 8-K 5.02,5.07,8.01,9.01 0001193125-26-116123 001-39503 26774940 34 1012900 1 1
2026-03-10 DEFR14A DEFR14A 0001193125-26-100178 001-39503 26739590 34 147367 1 1
2026-03-05 4 xslF345X05/form4-03062026_120343.xml 0001604834-26-000006 12531
2026-03-05 4 xslF345X05/form4-03062026_120318.xml 0002037968-26-000004 9881
2026-03-05 4 xslF345X05/form4-03062026_120320.xml 0001861464-26-000004 9834
2026-03-05 4 xslF345X05/form4-03062026_120346.xml 0001822499-26-000004 9834
2026-03-05 4 xslF345X05/form4-03052026_110324.xml 0001794629-26-000004 9846
2026-03-04 144 xsl144X01/primary_doc.xml 0001604834-26-000004 001-39503 26723628 33 5628
2026-02-23 DEF 14A DEF 14A 0001193125-26-063952 001-39503 26665094 34 3617753 1 1
2026-02-20 CORRESP filename1.htm 0001193125-26-061471 88724
2026-02-11 UPLOAD filename1.pdf 0000000000-26-001440 333-292829 43601
2026-02-11 UPLOAD filename1.pdf 0000000000-26-001439 333-292826 43602
2026-02-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001957912-26-000008 005-91705 26608083 34 17902
2026-02-04 PRE 14A PRE 14A 0001193125-26-037767 001-39503 26599114 34 2339911 1 1
2026-01-20 S-3 S-3 0001193125-26-016699 333-292829 26543497 33 1110852 1 1
2026-01-20 S-3 S-3 0001193125-26-016629 333-292826 26543205 33 1953086 1 1
2026-01-16 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-015471 005-91705 26540113 34 12425
2026-01-09 8-K 8-K 5.02,5.03,7.01,8.01,9.01 0001193125-26-008904 001-39503 26523094 34 1043766 1 1
2026-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001636587-26-000001 005-91705 26520710 34 12431
2026-01-05 4 xslF345X05/form4-01062026_120132.xml 0001794629-26-000002 10523
2026-01-05 4 xslF345X05/form4-01062026_120146.xml 0001604834-26-000002 13207
2026-01-05 4 xslF345X05/form4-01062026_120150.xml 0002037968-26-000002 12863
2026-01-05 4 xslF345X05/form4-01062026_120110.xml 0001822499-26-000002 12816
2026-01-05 4 xslF345X05/form4-01062026_120121.xml 0001861464-26-000002 10506
2025-12-29 4 xslF345X05/form4-12292025_091202.xml 0002037968-25-000003 6367
2025-12-29 4 xslF345X05/form4-12292025_091231.xml 0001604834-25-000004 6367
2025-12-29 4 xslF345X05/form4-12292025_091245.xml 0001822499-25-000005 6319
2025-12-29 4 xslF345X05/form4-12292025_091206.xml 0001794629-25-000003 6322
2025-12-29 4 xslF345X05/form4-12292025_091201.xml 0001861464-25-000003 6319
2025-12-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-331145 005-91705 251601725 34 27702
2025-12-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000979 32462
2025-12-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001636587-25-000065 005-91705 251601330 34 12381
2025-12-22 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-328818 005-91705 251592829 34 15568
2025-12-18 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001373604-25-000127 005-91705 251582940 34 7636
2025-12-18 8-K/A 8-K/A 1.01,3.02,7.01,8.01,9.01 0001193125-25-323786 001-39503 251581368 34 27769071 1 1
2025-12-18 8-K 8-K 1.01,3.02,7.01,8.01,9.01 0001193125-25-323692 001-39503 251581263 34 27256022 1 1
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001957912-25-000008 005-91705 251485931 34 17643
2025-11-06 10-Q 10-Q 0001193125-25-269544 001-39503 251458426 34 10766977 1 1
2025-11-06 8-K 8-K 2.02,7.01,9.01 0001193125-25-269506 001-39503 251458310 34 393450 1 1
2025-10-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001376474-25-000840 005-91705 251388505 34 9733
2025-10-03 8-K 8-K 8.01 0001193125-25-229293 001-39503 251372208 34 157867 1 1
2025-09-11 8-K 8-K 3.03,5.03,9.01 0000950170-25-114093 001-39503 251307315 34 300208 1 1
2025-08-07 10-Q 10-Q 0000950170-25-105052 001-39503 251194286 34 9098141 1 1
2025-08-07 8-K 8-K 2.02,7.01,9.01 0000950170-25-105029 001-39503 251194105 34 392507 1 1
2025-07-02 4 xslF345X05/form4-07022025_080725.xml 0001415889-25-019070 12261
2025-07-02 4 xslF345X05/form4-07022025_080737.xml 0001415889-25-019069 12619
2025-07-02 4 xslF345X05/form4-07022025_080743.xml 0001415889-25-019068 9971
2025-07-02 4 xslF345X05/form4-07022025_080700.xml 0001415889-25-019066 9960
2025-07-02 4 xslF345X05/form4-07022025_080705.xml 0001415889-25-019064 12311
2025-07-01 144 xsl144X01/primary_doc.xml 0001415889-25-018810 001-39503 251097988 33 4753
2025-07-01 144 xsl144X01/primary_doc.xml 0001415889-25-018808 001-39503 251097985 33 4669
2025-07-01 144 xsl144X01/primary_doc.xml 0001415889-25-018806 001-39503 251097981 33 4654
2025-07-01 144 xsl144X01/primary_doc.xml 0001415889-25-018804 001-39503 251097977 33 4663
2025-06-03 4 xslF345X05/form4-06032025_090659.xml 0001415889-25-015441 5549
2025-06-03 4 xslF345X05/form4-06032025_090615.xml 0001415889-25-015440 5653
2025-06-03 4 xslF345X05/form4-06032025_090622.xml 0001415889-25-015439 5683
2025-06-03 4 xslF345X05/form4-06032025_090642.xml 0001415889-25-015438 5689
2025-06-03 4 xslF345X05/form4-06032025_090605.xml 0001415889-25-015436 5681
2025-06-03 4 xslF345X05/form4-06032025_090644.xml 0001415889-25-015434 5642
2025-06-03 4 xslF345X05/form4-06032025_090653.xml 0001415889-25-015431 5687
2025-06-02 8-K 8-K 5.07 0000950170-25-080234 001-39503 251014918 34 174173 1 1
2025-05-09 10-Q 10-Q 0000950170-25-068040 001-39503 25930610 34 8274426 1 1
2025-05-09 8-K 8-K 2.02,7.01,9.01 0000950170-25-068020 001-39503 25930501 34 399231 1 1
2025-04-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-035511 005-91705 25843081 34 10598
2025-04-16 8-K 8-K 3.01 0000950170-25-054707 001-39503 25842734 34 171433 1 1
2025-04-14 ARS ARS 0001140361-25-013774 001-39503 25836407 34 2901579
2025-04-14 DEFA14A DEFA14A 0001140361-25-013773 001-39503 25836402 34 2607014
2025-04-14 DEF 14A DEF 14A 0001140361-25-013769 001-39503 25836376 34 6549490 1 1
2025-04-04 PRE 14A PRE 14A 0001140361-25-012299 001-39503 25813887 34 6674657 1 1
2025-03-12 4/A xslF345X05/form4a-03122025_090335.xml 0001415889-25-007858 6144
2025-03-04 4 xslF345X05/form4-03042025_090322.xml 0001415889-25-006553 10863
2025-03-04 4 xslF345X05/form4-03042025_090334.xml 0001415889-25-006552 8237
2025-03-04 4 xslF345X05/form4-03042025_090341.xml 0001415889-25-006536 8227
2025-03-04 4 xslF345X05/form4-03042025_090304.xml 0001415889-25-006534 8234
2025-03-04 4 xslF345X05/form4-03042025_090321.xml 0001415889-25-006531 8228
2025-02-27 S-8 S-8 0000950170-25-029109 333-285345 25679567 33 766606
2025-02-27 10-K 10-K 0000950170-25-029069 001-39503 25678994 34 16647631 1 1
2025-02-27 8-K 8-K 2.02,7.01,9.01 0000950170-25-029038 001-39503 25678804 34 379279 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001373604-25-000030 005-91705 25624474 34 7866
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001373604-25-000027 005-91705 25624265 34 7670
2025-01-03 4 xslF345X05/form4-01032025_100122.xml 0001415889-25-000544 9976
2025-01-03 4 xslF345X05/form4-01032025_100106.xml 0001415889-25-000536 12615
2025-01-03 4 xslF345X05/form4-01032025_100111.xml 0001415889-25-000534 12287
2025-01-03 4 xslF345X05/form4-01032025_100141.xml 0001415889-25-000527 12305
2025-01-03 4 xslF345X05/form4-01032025_100141.xml 0001415889-25-000525 12268
2025-01-02 144 xsl144X01/primary_doc.xml 0001415889-25-000228 001-39503 25503529 33 4675
2025-01-02 144 xsl144X01/primary_doc.xml 0001415889-25-000226 001-39503 25503525 33 4760
2025-01-02 144 xsl144X01/primary_doc.xml 0001415889-25-000224 001-39503 25503522 33 4669
2025-01-02 144 xsl144X01/primary_doc.xml 0001415889-25-000222 001-39503 25503519 33 4679
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-118955 005-91705 241462644 34 95011
2024-11-07 10-Q 10-Q 0000950170-24-123372 001-39503 241435962 34 7973186 1 1
2024-11-07 8-K 8-K 2.02,7.01,9.01 0000950170-24-123324 001-39503 241435719 34 312079 1 1
2024-11-07 SC 13G atha13g.htm 0001373604-24-000108 005-91705 241434430 34 77725
2024-10-31 SC 13D/A SC 13D/A 0001193125-24-248699 005-91705 241415451 34 72642
2024-10-28 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-10-28 16:00:00 9999999995-24-003298 333-282738 241402431 33 1828
2024-10-24 UPLOAD filename1.pdf 0000000000-24-011896 333-282738 40136
2024-10-24 CORRESP filename1.htm 0000950170-24-116975 18143
2024-10-21 S-3 S-3 0000950170-24-115736 333-282738 241381924 33 1318699
2024-10-18 8-K 8-K 3.01,8.01 0000950170-24-115592 001-39503 241380749 34 170888 1 1
2024-10-07 8-K 8-K 5.02,9.01 0000950170-24-113210 001-39503 241357824 34 1716290 1 1
2024-10-03 4/A xslF345X05/form4a-10042024_011037.xml 0001415889-24-024712 5831
2024-10-03 4 xslF345X05/form4-10032024_111030.xml 0001415889-24-024686 8241
2024-10-03 4 xslF345X05/form4-10032024_111055.xml 0001415889-24-024685 8222
2024-10-03 4 xslF345X05/form4-10032024_111019.xml 0001415889-24-024684 8238
2024-10-03 4 xslF345X05/form4-10032024_111033.xml 0001415889-24-024683 8219
2024-10-03 4 xslF345X05/form4-10032024_111021.xml 0001415889-24-024680 8212
2024-10-03 3 xslF345X02/form3-10032024_111049.xml 0001415889-24-024678 17560
2024-09-17 8-K 8-K 2.05,5.02,9.01 0000950170-24-107031 001-39503 241302692 34 485393 1 1
2024-09-05 144 xsl144X01/primary_doc.xml 0001415889-24-022989 001-39503 241282673 33 4757
2024-09-05 4 xslF345X05/form4-09052024_110900.xml 0001415889-24-022987 10557
2024-09-05 4 xslF345X05/form4-09052024_110919.xml 0001415889-24-022986 8494
2024-09-05 4 xslF345X05/form4-09052024_110908.xml 0001415889-24-022985 10787
2024-09-05 4 xslF345X05/form4-09052024_110917.xml 0001415889-24-022984 10761
2024-09-05 4 xslF345X05/form4-09052024_110923.xml 0001415889-24-022983 11114
2024-09-03 8-K 8-K 7.01,8.01,9.01 0000950170-24-102788 001-39503 241273923 34 7826035 1 1
2024-08-09 10-Q/A 10-Q/A 0000950170-24-094738 001-39503 241192532 34 1722788 1 1
2024-08-01 10-Q 10-Q 0000950170-24-089304 001-39503 241166889 34 7644289 1 1
2024-08-01 8-K 8-K 2.02,7.01,9.01 0000950170-24-089281 001-39503 241166711 34 320872 1 1
2024-06-25 4 xslF345X05/form4-06252024_110651.xml 0001415889-24-018177 7081
2024-05-29 8-K 8-K 5.07,9.01 0000950170-24-065914 001-39503 24998308 34 192026 1 1
2024-05-24 4 xslF345X05/form4-05242024_110538.xml 0001415889-24-014582 5687
2024-05-24 4 xslF345X05/form4-05242024_110543.xml 0001415889-24-014580 5693
2024-05-24 4 xslF345X05/form4-05242024_100557.xml 0001415889-24-014578 5685
2024-05-24 4 xslF345X05/form4-05242024_100520.xml 0001415889-24-014576 5646
2024-05-24 4 xslF345X05/form4-05242024_100543.xml 0001415889-24-014573 5657
2024-05-24 4 xslF345X05/form4-05242024_100527.xml 0001415889-24-014571 5691
2024-05-24 4 xslF345X05/form4-05242024_100557.xml 0001415889-24-014569 5553
2024-05-17 8-K 8-K 8.01,9.01 0000950170-24-061837 001-39503 24961061 34 200233 1 1
2024-05-15 10-Q 10-Q 0000950170-24-060482 001-39503 24950967 34 7191641 1 1
2024-05-15 8-K 8-K 2.02,7.01,9.01 0000950170-24-060452 001-39503 24950668 34 341538 1 1
2024-04-16 4 xslF345X05/form4-04162024_080456.xml 0001415889-24-010877 5765
2024-04-16 3 xslF345X02/form3-04162024_080435.xml 0001415889-24-010876 3222
2024-04-09 ARS ARS 0001140361-24-018754 001-39503 24831231 34 4963732
2024-04-09 DEFA14A DEFA14A 0001140361-24-018752 001-39503 24831228 34 773463
2024-04-09 DEF 14A DEF 14A 0001140361-24-018750 001-39503 24831225 34 3629265
2024-03-28 PRE 14A PRE 14A 0001140361-24-015918 001-39503 24793793 34 3520446
2024-02-22 S-8 S-8 0000950170-24-018825 333-277276 24665416 33 482206
2024-02-22 10-K 10-K 0000950170-24-018787 001-39503 24664994 34 12023651 1 1
2024-02-22 8-K 8-K 2.02,5.02,7.01,9.01 0000950170-24-018764 001-39503 24664805 34 833368 1 1
2024-02-16 4 xslF345X05/form4-02162024_100218.xml 0001415889-24-004166 5636
2024-02-16 4 xslF345X05/form4-02162024_100213.xml 0001415889-24-004165 5655
2024-02-16 4 xslF345X05/form4-02162024_090202.xml 0001415889-24-004159 5673
2024-02-16 4 xslF345X05/form4-02162024_090245.xml 0001415889-24-004158 5680
2024-02-16 4 xslF345X05/form4-02162024_090230.xml 0001415889-24-004157 5690
2024-02-16 4/A xslF345X05/form4a-02162024_090222.xml 0001415889-24-004155 8520
2024-02-16 4/A xslF345X05/form4a-02162024_090229.xml 0001415889-24-004153 11120
2024-02-16 4/A xslF345X05/form4a-02162024_090252.xml 0001415889-24-004151 10786
2024-02-16 4/A xslF345X05/form4a-02162024_090259.xml 0001415889-24-004149 8585
2024-02-16 4/A xslF345X05/form4a-02162024_090254.xml 0001415889-24-004146 13360
2024-02-14 SC 13G SC 13G 0001104659-24-023744 005-91705 24638762 34 106457
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001157 6064
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001153 8255
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001150 11086
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001145 10822
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001142 13103
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001138 8476
2024-01-08 8-K 8-K 2.02,5.02,9.01 0000950170-24-002686 001-39503 24518316 34 488113 1 1
2023-12-29 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-023291 13227
2023-12-29 SC 13D/A SC 13D/A 0001193125-23-306018 005-91705 231528565 34 60387
2023-11-09 10-Q 10-Q 0000950170-23-062082 001-39503 231392649 34 8687696 1 1
2023-11-09 8-K 8-K 2.02,7.01,9.01 0000950170-23-062045 001-39503 231392459 34 361303 1 1
2023-08-10 10-Q 10-Q 0000950170-23-041346 001-39503 231159718 34 9505018 1 1
2023-08-10 8-K 8-K 2.02,7.01,9.01 0000950170-23-041320 001-39503 231159441 34 390656 1 1
2023-07-07 SC 13G/A us04746l1044_070723.txt 0001306550-23-009576 005-91705 231077297 34 12400
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035951 8929
2023-06-06 4 FORM 4 SUBMISSION 0001209191-23-034887 16208
2023-06-06 4 FORM 4 SUBMISSION 0001209191-23-034886 9418
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031580 7719
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031576 7730
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031572 7683
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031566 7740
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031559 7696
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031557 7605
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031554 7722
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031552 8361
2023-05-22 3 FORM 3 SUBMISSION 0001209191-23-031550 4828
2023-05-22 8-K 8-K 5.02,5.07,8.01,9.01 0001193125-23-149921 001-39503 23942465 34 545831 1 1
2023-05-11 10-Q 10-Q 0000950170-23-021274 001-39503 23911319 34 9034937 1 1
2023-05-11 8-K 8-K 2.02,7.01,9.01 0000950170-23-021239 001-39503 23911121 34 379639 1 1
2023-04-20 SC 13G SCHEDULE 13G 0000899140-23-000543 005-91705 23834039 34 36384
2023-04-05 ARS ARS 0001140361-23-016531 001-39503 23801171 34 7960836
2023-04-05 DEFA14A FORM DEFA14A 0001140361-23-016529 001-39503 23801169 34 887064
2023-04-05 DEF 14A DEF 14A 0001140361-23-016527 001-39503 23801166 34 1565034
2023-03-31 4 FORM 4 SUBMISSION 0001209191-23-021878 7311
2023-03-30 4 FORM 4 SUBMISSION 0001209191-23-021708 4613
2023-03-27 4 FORM 4 SUBMISSION 0001209191-23-021248 7064
2023-03-23 S-8 S-8 0000950170-23-009530 333-270792 23756743 33 567753
2023-03-23 10-K 10-K 0000950170-23-009498 001-39503 23756398 34 15651626 1 1
2023-03-23 8-K 8-K 2.02,7.01,9.01 0000950170-23-009483 001-39503 23756257 34 418413 1 1
2023-02-14 SC 13G/A ATHIRA PHARMA, INC. 0000902664-23-001740 005-91705 23624083 34 64210
2023-02-01 SC 13G/A us04746l1044_020123.txt 0001306550-23-006417 005-91705 23577468 34 13182
2023-01-31 4 FORM 4 SUBMISSION 0001209191-23-005818 10552
2023-01-30 SC 13G/A athi22a1.htm 0000038777-23-000012 005-91705 23566608 34 186597
2023-01-23 4 FORM 4 SUBMISSION 0001209191-23-004481 5520
2023-01-23 4 FORM 4 SUBMISSION 0001209191-23-004480 5496
2023-01-23 4 FORM 4 SUBMISSION 0001209191-23-004478 5467
2023-01-23 4 FORM 4 SUBMISSION 0001209191-23-004475 5528
2023-01-23 4 FORM 4 SUBMISSION 0001209191-23-004468 7904
2023-01-06 8-K 8-K 1.01,2.02,9.01 0000950170-23-000364 001-39503 23516056 34 809709 1 1
2023-01-06 424B5 424B5 0000950170-23-000361 333-261073 23516033 33 1787264
2022-12-30 4 FORM 4 SUBMISSION 0001209191-22-063009 7420
2022-12-06 4 FORM 4 SUBMISSION 0001209191-22-060128 5041
2022-11-18 8-K 8-K 5.03,9.01 0000950170-22-025442 001-39503 221401965 34 572725 1 1
2022-11-17 4 FORM 4 SUBMISSION 0001209191-22-057721 4628
2022-11-10 10-Q 10-Q 0000950170-22-024499 001-39503 221377586 34 10000619 1 1
2022-11-10 8-K 8-K 2.02,7.01,9.01 0000950170-22-024464 001-39503 221377279 34 417491 1 1
2022-10-31 4 FORM 4 SUBMISSION 0001209191-22-054950 7034
2022-10-17 4 FORM 4 SUBMISSION 0001209191-22-053869 7034
2022-10-17 8-K 8-K 7.01,8.01,9.01 0000950170-22-019592 001-39503 221312607 34 1325205 1 1
2022-08-15 10-Q 10-Q 0000950170-22-017421 001-39503 221166806 34 10076299 1 1
2022-08-15 8-K 8-K 2.02,7.01,9.01 0000950170-22-017392 001-39503 221166157 34 417852 1 1
2022-07-01 SC 13D/A SC 13D/A 0001193125-22-187269 005-91705 221062058 34 62308
2022-07-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-015719 11032
2022-06-30 4 FORM 4 SUBMISSION 0001209191-22-039937 4627
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039344 10473
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039343 8068
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039342 10423
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039340 13099
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039338 8126
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039336 8104
2022-06-22 8-K 8-K 7.01,8.01,9.01 0000950170-22-011935 001-39503 221029942 34 2250673 1 1
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036067 9401
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032699 5577
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032696 5576
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032693 5535
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032690 5595
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032687 5450
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032684 5587
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032681 5543
2022-05-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-013738 7962
2022-05-24 8-K 8-K 5.07 0001193125-22-158630 001-39503 22957880 34 163873 1 1
2022-05-17 DEFA14A DEFA14A 0001193125-22-152368 001-39503 22932149 34 16239
2022-05-17 DEFA14A DEFA14A 0001193125-22-152128 001-39503 22931557 34 29285
2022-05-16 DFAN14A DFAN 14A 0000899140-22-000523 001-39503 22927631 34 32897
2022-05-12 10-Q 10-Q 0000950170-22-009683 001-39503 22918104 34 8463978 1 1
2022-05-12 8-K 8-K 2.02,7.01,9.01 0000950170-22-009670 001-39503 22917930 34 415469 1 1
2022-05-12 DFAN14A DFAN 14A 0000899140-22-000521 001-39503 22917146 34 60069
2022-05-11 DEFA14A DEFA14A 0001193125-22-147598 001-39503 22914459 34 48886
2022-05-09 DEFA14A DEFA14A 0001193125-22-145053 001-39503 22905570 34 27759
2022-05-05 DEFA14A DEFA14A 0001193125-22-142271 001-39503 22896005 34 60211
2022-05-05 DFAN14A SCHEDULE 14A INFORMATION 0000899140-22-000504 001-39503 22894816 34 41100
2022-05-05 DEFA14A DEFA14A 0001193125-22-141398 001-39503 22894208 34 29774
2022-05-05 DEFA14A DEFA14A 0001193125-22-141396 001-39503 22894192 34 56826
2022-05-04 DFAN14A DFAN 14A 0000899140-22-000499 001-39503 22890382 34 37608
2022-05-02 DFAN14A SCHEDULE DFAN14A - DEFINITIVE ADDITIONAL MATERIALS 0000899140-22-000492 001-39503 22883022 34 30040
2022-04-27 DFAN14A SCHEDULE 14A INFORMATION 0000899140-22-000481 001-39503 22858901 34 80175
2022-04-26 DEFA14A DEFA14A 0001193125-22-118948 001-39503 22851856 34 67559
2022-04-26 DEFA14A DEFA14A 0001193125-22-118943 001-39503 22851848 34 9965682
2022-04-25 DFAN14A SCHEDULE 14A INFORMATION 0000899140-22-000479 001-39503 22849534 34 12270275
2022-04-22 DFAN14A SCHEDULE 14A INFORMATION 0000899140-22-000469 001-39503 22844020 34 1403661
2022-04-20 DEFA14A DEFA14A 0001193125-22-111084 001-39503 22838028 34 813883
2022-04-13 DFAN14A SCHEDULE 14A INFORMATION 0000899140-22-000464 001-39503 22825473 34 46211
2022-04-12 4 FORM 4 SUBMISSION 0001209191-22-024219 7042
2022-04-11 DEFA14A DEFA14A 0001193125-22-101729 001-39503 22820071 34 12189
2022-04-11 DEFA14A DEFA14A 0001193125-22-101725 001-39503 22820051 34 13966549
2022-04-11 DFAN14A DFAN14A 0001193125-22-101062 001-39503 22818569 34 36570
2022-04-11 DEFC14A DEFC14A 0001193125-22-101009 001-39503 22818546 34 359802
2022-04-08 PREC14A PREC14A 0001193125-22-100161 001-39503 22817264 34 360694
2022-04-06 UPLOAD filename1.pdf 0000000000-22-003709 46248
2022-04-05 DEFA14A DEFA14A 0001193125-22-096282 001-39503 22807941 34 58389
2022-04-05 DEFC14A DEFC14A 0001564590-22-013569 001-39503 22806833 34 1592040
2022-04-01 4 FORM 4 SUBMISSION 0001209191-22-022001 4571
2022-03-30 PREC14A PREC14A 0001193125-22-090028 001-39503 22787839 34 366193
2022-03-30 DEFA14A DEFA14A 0001564590-22-012590 001-39503 22786331 34 144934
2022-03-30 DFAN14A DFAN14A 0001193125-22-088943 001-39503 22783710 34 47437
2022-03-28 DEFA14A DEFA14A 0001193125-22-086878 001-39503 22776550 34 16150
2022-03-28 S-8 S-8 0001564590-22-012003 333-263907 22776342 33 424479
2022-03-28 10-K 10-K 0000950170-22-004782 001-39503 22775582 34 17650759 1 1
2022-03-25 CORRESP filename1.htm 0001564590-22-011836 184379
2022-03-25 PREC14A PREC14A 0001564590-22-011834 001-39503 22772396 34 1550352
2022-03-24 8-K 8-K 2.02,7.01,9.01 0000950170-22-004547 001-39503 22766601 34 395866 1 1
2022-03-21 4 FORM 4 SUBMISSION 0001209191-22-020266 5395
2022-03-21 3 FORM 3 SUBMISSION 0001209191-22-020263 6789
2022-03-21 3/A FORM 3/A SUBMISSION 0001209191-22-020262 3877
2022-03-21 8-K 8-K 5.02,9.01 0001193125-22-080027 001-39503 22754209 34 187432 1 1
2022-02-18 4 FORM 4 SUBMISSION 0001209191-22-011485 6944
2022-02-14 SC 13G/A SC 13G/A 0001140361-22-005380 005-91705 22634300 34 294709
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022816 005-91705 22632058 34 196963
2022-02-14 SC 13G/A ATHIRA PHARMA, INC. 0000902664-22-001582 005-91705 22625428 34 64707
2022-02-04 SC 13G us04746l1044_020422.txt 0000834237-22-007252 005-91705 22593485 34 13217
2022-02-03 SC 13G athi21in.htm 0000038777-22-000015 005-91705 22587261 34 205886
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005628 10557
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005622 5434
2022-01-31 3 FORM 3 SUBMISSION 0001209191-22-005614 6848
2022-01-31 8-K 8-K 5.02,8.01,9.01 0001193125-22-023358 001-39503 22574159 34 308962 1 1
2022-01-20 4 FORM 4 SUBMISSION 0001209191-22-004129 5530
2022-01-20 4 FORM 4 SUBMISSION 0001209191-22-004123 5469
2022-01-20 4 FORM 4 SUBMISSION 0001209191-22-004122 5522
2022-01-20 4 FORM 4 SUBMISSION 0001209191-22-004120 7909
2022-01-20 4 FORM 4 SUBMISSION 0001209191-22-004118 7931
2022-01-06 4 FORM 4 SUBMISSION 0001209191-22-002218 9275
2021-11-24 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-11-24 16:00:00 9999999995-21-004485 333-261073 211449040 33 1779
2021-11-22 CORRESP filename1.htm 0001193125-21-336955 7791
2021-11-22 UPLOAD filename1.pdf 0000000000-21-014153 40274
2021-11-15 S-3 S-3 0001564590-21-057000 333-261073 211410377 33 1482983
2021-11-10 10-Q 10-Q 0000950170-21-004091 001-39503 211396901 34 10743474 1 1
2021-11-10 8-K 8-K 2.02,7.01,9.01 0000950170-21-004081 001-39503 211396710 34 541337 1 1
2021-11-05 4 FORM 4 SUBMISSION 0001209191-21-063208 5506
2021-11-05 4 FORM 4 SUBMISSION 0001209191-21-063207 5515
2021-10-21 8-K 8-K 5.02,8.01,9.01 0001193125-21-304002 001-39503 211337116 34 320140 1 1
2021-08-19 4 FORM 4 SUBMISSION 0001209191-21-052564 12107
2021-08-16 10-Q 10-Q 0001564590-21-044641 001-39503 211178473 34 10834257 1 1
2021-08-16 8-K 8-K 2.02,7.01,9.01 0001564590-21-044631 001-39503 211178236 34 497705 1 1
2021-08-09 8-K 8-K 8.01,9.01 0001193125-21-239806 001-39503 211154490 34 185686 1 1
2021-07-21 4 FORM 4 SUBMISSION 0001209191-21-047601 13250
2021-06-21 8-K 8-K 5.02,9.01 0001193125-21-193538 001-39503 211026911 34 196442 1 1
2021-06-16 4 FORM 4 SUBMISSION 0001209191-21-041084 7538
2021-06-14 3 FORM 3 SUBMISSION 0001209191-21-040268 6951
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039627 9334
2021-06-10 4/A FORM 4/A SUBMISSION 0001209191-21-039625 9461
2021-06-09 4 FORM 4 SUBMISSION 0001209191-21-039242 6954
2021-06-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-005266 8005
2021-06-01 3 FORM 3 SUBMISSION 0001209191-21-036925 6918
2021-06-01 4 FORM 4 SUBMISSION 0001209191-21-036919 5342
2021-06-01 4 FORM 4 SUBMISSION 0001209191-21-036916 5470
2021-06-01 4 FORM 4 SUBMISSION 0001209191-21-036915 5479
2021-06-01 4 FORM 4 SUBMISSION 0001209191-21-036913 5487
2021-06-01 8-K 8-K 5.07 0001564590-21-031155 001-39503 21985263 34 178006 1 1
2021-05-13 10-Q 10-Q 0001564590-21-027607 001-39503 21920249 34 9717438 1 1
2021-05-13 8-K 8-K 2.02,7.01,9.01 0001564590-21-027547 001-39503 21919721 34 485572 1 1
2021-04-16 DEFA14A DEFA14A 0001564590-21-019081 001-39503 21830067 34 469348
2021-04-16 DEF 14A DEF 14A 0001564590-21-019074 001-39503 21830020 34 2345231
2021-03-26 S-8 S-8 0001564590-21-015631 333-254735 21774268 33 375545
2021-03-25 10-K 10-K 0001564590-21-015495 001-39503 21772570 34 13400730 1
2021-03-25 8-K 8-K 2.02,7.01,9.01 0001564590-21-015484 001-39503 21772461 34 225829
2021-03-08 4 FORM 4 SUBMISSION 0001209191-21-018569 5386
2021-03-08 3 FORM 3 SUBMISSION 0001209191-21-018560 6812
2021-03-08 8-K 8-K 5.02,9.01 0001564590-21-011353 001-39503 21720583 34 72750
2021-02-22 4 FORM 4 SUBMISSION 0001209191-21-012823 5474
2021-02-22 4 FORM 4 SUBMISSION 0001209191-21-012822 5445
2021-02-22 4 FORM 4 SUBMISSION 0001209191-21-012819 5461
2021-02-22 4 FORM 4 SUBMISSION 0001209191-21-012816 5469
2021-02-22 4 FORM 4 SUBMISSION 0001209191-21-012813 5480
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-023916 005-91705 21638119 34 265305

Latest XBRL company facts

One latest value per concept from companyfacts (227 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 13.08M 2026-11-12 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
dei EntityPublicFloat Entity Public Float USD 9.90M 2025-06-30 2025 FY 10-K 2026-03-31 0001193125-26-134565
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 886,859 2025-01-01 2025-12-31 DEF 14A 2026-05-11 0001193125-26-216742
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 770,805 2025-01-01 2025-12-31 DEF 14A 2026-05-11 0001193125-26-216742
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 1.95M 2025-01-01 2025-12-31 DEF 14A 2026-05-11 0001193125-26-216742
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.42M 2025-01-01 2025-12-31 DEF 14A 2026-05-11 0001193125-26-216742
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 31,000 2025-01-01 2025-12-31 DEF 14A 2026-05-11 0001193125-26-216742
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 788,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 634,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap AccretionExpense Accretion Expense USD 172,000 2020-01-01 2020-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027607
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 6.08M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 4.95M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -12,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 600.90M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.59M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 3.50M 2020-04-01 2020-06-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004091
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 7.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 50.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap Assets Assets USD 38.14M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap AssetsCurrent Assets, Current USD 36.33M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 6,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009683
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 500.00M 2026-03-18 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 16.34M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 16.97M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -52.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 65.27M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 400.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 9.93M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 9.93M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -73.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 92.54M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004782
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 1.55M 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap CostsAndExpenses Costs and Expenses USD 58.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 241,000 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 14.94M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 112.86M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 25.20M 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018787
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 56.89M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 258,000 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029069
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 352,000 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 12.93M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.29M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 369,000 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 112.62M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DeferredTaxLiabilitiesInvestments Deferred Tax Liabilities, Investments USD 19,000 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 109,000 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap Depreciation Depreciation USD 678,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -445,000 2020-01-01 2020-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027607
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 999,000 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap DueFromRelatedParties Due from Related Parties USD 36,000 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 7,000 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap DueFromRelatedPartiesNoncurrent Due from Related Parties, Noncurrent USD 29,000 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.2 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017421
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.192 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.018 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.87M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 36.10M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 16.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -7,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 199,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004782
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 20.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -105.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -19.95M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 20.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -22.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 669,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 759,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -2.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap IncreaseDecreaseInInsuranceSettlementsReceivable Increase (Decrease) in Insurance Settlements Receivable USD -1.63M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap IncreaseDecreaseInOperatingAssets Increase (Decrease) in Operating Assets USD -308,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027607
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -343,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -564,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap InsuranceRecoveries Insurance Recoveries USD 1.63M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029069
us-gaap InsuranceSettlementsReceivableCurrent Insurance Settlements Receivable, Current USD 1.63M 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029069
us-gaap InterestAndOtherIncome Interest and Other Income USD 1.66M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024499
us-gaap InterestExpense Interest Expense USD 2,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009683
us-gaap InvestmentsAndCash Investments and Cash USD 32.30M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 476,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 494,000 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 130,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 286,000 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 494,000 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004782
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 509,000 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018787
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 346,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 126,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269544
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 16,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap Liabilities Liabilities USD 22.12M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 38.14M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap LiabilitiesCurrent Liabilities, Current USD 7.33M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap LitigationReserve Estimated Litigation Liability USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 4.13M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap LongTermInvestments Long-term Investments USD 44.83M 2022-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018787
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 4.10M 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029069
us-gaap LossContingencyAccrualCarryingValueCurrent Loss Contingency, Accrual, Current USD 10.00M 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029069
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 4.10M 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029069
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD -56.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 114,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 3.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -56.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -73.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.65M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024499
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -58.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OperatingLeaseCost Operating Lease, Cost USD 265,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 265,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062082
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 460,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 460,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 338,000 2025-12-31 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OperatingLeasePayments Operating Lease, Payments USD 21,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 308,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 227,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.081 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 259.80M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 64,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -33,000 2021-07-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004091
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -3,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 840,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap OtherNoncashExpense Other Noncash Expense USD 1.40M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004782
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 4,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024499
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 46,000 2020-01-01 2020-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027607
us-gaap PaymentsForLegalSettlements Payments for Legal Settlements USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-105052
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 209,000 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-16 0001564590-21-044641
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 7.60M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 38.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 16.29M 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-03-18 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 100.00M 2026-03-18 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 4.02M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ProceedsFromCollectionOfLoansReceivable Proceeds from Collection of Loans Receivable USD 36,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004782
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 1.66M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004782
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 96.76M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009498
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 89.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 90.00M 2025-12-01 2025-12-31 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 42.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 18.05M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004091
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 18.05M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009498
us-gaap ProceedsFromShortTermDebtMaturingInThreeMonthsOrLess Proceeds from Short-term Debt, Maturing in Three Months or Less USD 215,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053574
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 99,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021274
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -73.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 5.75M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 800,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 2,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053574
us-gaap RepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess Repayments of Short-term Debt, Maturing in Three Months or Less USD 215,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053574
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 38.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 8.37M 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123372
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 631,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap RestructuringAndRelatedCostCostIncurredToDate1 Restructuring and Related Cost, Cost Incurred to Date USD 2.90M 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 2.90M 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029069
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.7 2024-09-15 2025 Q3 10-Q 2025-11-06 0001193125-25-269544
us-gaap RestructuringReserve Restructuring Reserve USD 400,000 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 400,000 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -584.87M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 680,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009498
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 8.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap SeveranceCosts1 Severance Costs USD 2.89M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029069
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 7.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.059 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 98,723 2025-12-31 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.03M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 41.89 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 47,513 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 27.9 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 4.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.09M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) shares 1.91M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-060482
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 14.72 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 2.73M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352243
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 5.06M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 9.2 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 4.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.16 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029069
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 9.3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap SharesOutstanding Shares, Outstanding shares 37.38M 2021-12-31 2022 Q3 10-Q 2022-11-10 0000950170-22-024499
us-gaap ShortTermInvestments Short-term Investments USD 15.97M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 16,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004091
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 10.59M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004782
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 16.02M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap StockIssued1 Stock Issued USD 4.51M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004782
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 75,660 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029069
us-gaap StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan Stock Issued During Period, Value, Employee Stock Ownership Plan USD 37,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 114,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 4.62M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004782
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 12,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 17.05M 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015495
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 4.31M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 30,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009498
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 190,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 20.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134565
us-gaap VariableLeaseCost Variable Lease, Cost USD 120,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 22.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 37.63M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017421
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 22.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463518

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →